CONT'D FROM THURSDAY ...
Putting the interest of drug company's bottom lines in front of patient welfare isn't new for ‘Big Pharma.’ Between 1994 and 2005, large pharmaceutical companies spent over $1.3 billion on lobbying politicians in the United States.
It's been said that if drug companies can use their influence to convince you that a state of mind is a mental illness, they can sell you something to make it better.
It's not just bean counters who think the report doesn't add up, over 10,000 mental health professionals, including an author of DSM-4 and a psychiatrist with 45 years’ experience, have signed a letter against DSM-5.
In Australia, Youth Mental Health advocate Patrick McGorry has described the revision as little more than incremental and desultory change.
"It's a bit of fine tuning around the edges of a classification system that's been in place for a hundred years in some respects," he said. "Just a label like schizophrenia or bipolar disorder is not sufficient to actually define treatment selections, so we've got to know what stage the illness is at."
So if you're feeling flat, fed up, filthy, or just a bit funny, chances are your condition can now be diagnosed, a drug prescribed to treat it, and you can go back to being classified as "normal."
No comments:
Post a Comment